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The present work is the first phytochemical investigation of Euphorbia davidii Subils. After multistep 
separation process, three flavonoid glycosides were obtained from the ethyl acetate soluble fraction of the 
methanol extract of the whole plant. The structures of the isolated compounds were determined as kaemp-
ferol 3-O-rhamnoside, myricetin 3-O-rhamnoside, and quercetin 3-O-rhamnoside. Aqueous and organic 
extracts of the plant were screened in vitro for antiproliferative activity against HeLa (cervix epithelial 
adenocarcinoma), A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma) and MCF7 (breast 
epithelial adenocarcinoma) cells, using the MTT assay. n-Hexane and chloroform extracts demonstrated 
moderately dose-dependent cell growth inhibitory activity against all four cell lines.
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Euphorbia species are reach in chemically and pharmacologically interesting second-
ary metabolites. Macrocyclic diterpenoids and their cyclisation products are the most 
important taxonomic markers in the Euphorbiaceae family in consequence of their 
extraordinary structural variability and limited distribution in the plant kingdom [11]. 
Besides specific Euphorbiaceae diterpenes, phenolic compounds (flavonoids, cou-
marins), other type diterpenoids and triterpenoids were isolated from different 
Euphorbia species [2, 3]. Many members of this family are used in folk medicine for 
the treatment of various diseases or have great economic importance like Ricinus 
communis L. and Manihot esculenta Crantz [9].
Euphorbia davidii Subils. is an invasive herbaceous annual weed, native in North 
America. Now, it has a scattered distribution in Europe (including Hungary) mostly 
with small populations restricted to railway areas and agricultural fields [1]. 
According to the latest molecular phylogeny and classification, E. davidii belongs to 
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the subsection Stormieae within the Euphorbia section Poinsettia [12]. Neither the 
phytochemical investigation of E. davidii nor its biological activity have been report-
ed previously.
Extensive phytochemical investigation was performed, in order to identify charac-
teristic secondary metabolites of E. davidii. The whole plants were collected in Igar, 
Hungary, in September 2011. A herbarium sample (No. 836) has been deposited in 
the Department of Pharmacognosy, University of Szeged, Szeged, Hungary. The fro-
zen fresh plant (15 kg) was percolated with 15 L methanol at room temperature. The 
crude extract was concentrated in vacuum and water was then added. The chlorophyll 
was removed by liquid-liquid extraction using CHCl3 (5 × 1500 mL). The aqueous 
methanolic residue was extracted with ethyl acetate (5 × 1000 mL). The dried organic 
phase (29 g) was fractionated by vacuum liquid chromatography (silica gel 330 g; 
eluent: ethyl acetate/ethanol/water 64:4:0, 64:4:2, 64:4:3, 64:8:3, 64:8:4, 64:16:8, 
64:32:16, 64:64:32; 1500 mL each) to yield 120 fractions. TLC monitoring of the 
fractions suggested, that fractions 4, 5 and 6 contain remarkable amounts of flavo-
noids. These fractions were first purified by preparative TLC (silica gel; ethyl acetate/
formic acid/water 85:10:5), and, finally, by HPLC (LiChrospher RP-18, 10 μm, 
250 × 10 mm; acetonitrile/water/formic acid 30:70:1, flow rate, 0.5 mL/min; 254 nm) 
to yield 1 (3.0 mg), 2 (3.0 mg) and 3 (3.0 mg).
Structures of 1–3 were established by NMR spectroscopy (Bruker Avance DRX 
500 spectrometer, δ in ppm rel. to Me4Si as internal standard, J in Hz). The 1H- and 
13C-NMR data of isolated compounds were identical with those of kaempferol 
3-O-rhamnoside [10], quercetin-O-rhamnoside [4, 5], and myricetin 3-O-rhamnoside 
[6] (Fig. 1).
Fig. 1. Chemical structure of flavonoid glycosides isolated from E. davidii. [1] kaempferol-3-O-rhamno-
side; [2] quercetin-3-O-rhamnoside; [3] myricetin 3-O-rhamnoside
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For pharmacological investigations 50 g of fresh plant material was extracted with 
500 mL methanol with the use of an ultrasonic bath. After filtration, the extract was 
evaporated to dryness under reduced pressure. The residue was dissolved in 50 mL 
50% aqueous methanol and was subjected to solvent–solvent partition between 
n-hexane (3×50 mL) and chloroform (3 × 50 mL). The n-hexane, chloroform and the 
residue phases were evaporated to dryness. After extraction with methanol, the dried 
plant material was extracted with 400 mL of boiling water for 15 min. The filtered 
extract was freeze-dried. All five extracts were screened in vitro for antiproliferative 
activity against HeLa (cervix epithelial adenocarcinoma), A431 (skin epidermoid 
carcinoma), A2780 (ovarian carcinoma) and MCF7 (breast epithelial adenocarcino-
ma) cells by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay [8]. All in vitro experiments were carried out on two microplates with 
at least five parallel wells. Cisplatin was used as reference compound. Stock solutions 
of the tested extracts (10 mg/mL) were prepared with DMSO. The cell lines were 
treated with extracts at concentrations of 10 or 30 mg/mL. The higher concentration 
of DMSO (0.3%) did not exert substantial action on the viability of the utilized cell 
lines [7]. Antiproliferative effects of extracts are presented in Table 1. 
In the course of our previous chemical screenings, 33 Euphorbiaceae species were 
tested for their diterpene content using the extraction and chromatographic methods 
published in ref. [11]. This investigation suggested, that diterpenes are not detectable 
in the extract of E. davidii [11]. Extensive literature searches on all species belonging 
to the section Poinsettia led to the conclusion that plants of this section are poorly 
investigated, and characteristic metabolites of this section are flavonoids and triterpe-
noids. Isolation of three flavonoid gylcosides from E. davidii confirms this establish-
ment. In our pharmacological investigation flavonoid containing ethyl acetate extract 
did not inhibit the proliferation of any cancer cell lines. However, n-hexane and 
Table 1
The antiproliferative effects of the prepared extracts against the utilized cancer cell lines
Extract Concentration (µg/mL)
Inhibition of cell growth (%) ± SEM
HeLa MCF7 A2780 A431
n-Hexane 10
30
14.60 ± 1.76
22.44 ± 2.66
33.07 ± 1.95
45.88 ± 1.58
19.39 ± 1.37
26.72 ± 0.91
18.11 ± 0.84
25.65 ± 2.99
Chloroform 10
30
–*
22.28 ± 2.74
30.81 ± 2.16
52.63 ± 0.88
21.83 ± 0.66
47.10 ± 0.68
–
21.64 ± 0.37
Ethyl acetate 10
30
–
–
–
–
–
–
–
–
50% methanol 10
30
–
–
–
15.84 ± 2.27
–
–
–
–
Water 10
30
–
–
–
27.89 ± 1.92
–
15.20 ± 0.80
–
–
*Extracts eliciting less than 10% inhibition of cancer cell proliferation were regarded as ineffective and the 
values are not presented.
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chloroform extracts demonstrated dose-dependent cell growth inhibitory activity 
against all cell lines. Bioassay guided phytochemical investigation of these lipophilic 
extracts would be a proper way of finding antiproliferative agents of E. davidii.
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